SEC Form 4 research
| Issuer | aTYR PHARMA INC |
|---|---|
| Tickers | LIFE, ATYR |
| Reporting owners | 68 |
| Officers and directors | 11 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-10-01 | Yaras Brandon | A | 410,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.